Erythropoietin(EPO), as the main mediator of erythropoiesis, is produced in tumor diseases not only by kidneys, but also by stromal tissue of the tumor, spleen, and liver to promote tumor growth by stimulating tumor angiogenesis and extramedullary erythropoiesis, resulting in increased oxygen perfusion [15]. This evidence concerns the gene EPO and neoplasm.